Nutritional support for an oncological patient receiving intensive drug antitumor treatment: a clinical case
https://doi.org/10.17650/2222-1468-2025-15-2-109-115
Abstract
Pancreatic cancer is one of the most aggressive types of oncological diseases and is often accompanied by various complications including malnutrition. Despite significant successes in the treatment of pancreatic cancer, late diagnosis, aggressive progression and resistance to traditional therapy methods complicate its treatment.
The article presents the causes, consequences and ways to correct malnutrition in patients with this malignant neoplasm, as well as a clinical case demonstrating the importance of nutritional deficiency screening and timely nutritional support in patients with pancreatic cancer during antitumor treatment.
About the Authors
F. U.-G. TankievaRussian Federation
Fatima Umat-Gireevna Tankieva
66 Sevastopolskiy Prospekt, Moscow 117593
M. B. Pak
Russian Federation
66 Sevastopolskiy Prospekt, Moscow 117593
S. V. Berelavichus
Russian Federation
66 Sevastopolskiy Prospekt, Moscow 117593
M. B. Rayevskaya
Russian Federation
66 Sevastopolskiy Prospekt, Moscow 117593
V. I. Stashkiv
Russian Federation
66 Sevastopolskiy Prospekt, Moscow 117593
E. A. Kirsanova
Russian Federation
Bld. 1, Riga Land, 26 km of Baltiya Road, Krasnogorsk District, Moscow Region 143421
References
1. Jin D., Khan N.U., Gu W. et al. Informatics strategies for early detection and risk mitigation in pancreatic cancer patients. Neoplasia 2025;60:101129. DOI: 10.1016/j.neo.2025.101129
2. Aoyama T., Maezawa Y., Hashimoto I. et al. Clinical impact of nutrition and inflammation assessment tools in pancreatic cancer treatment. Anticancer Res 2013;43(9):3849–60. DOI: 10.21873/anticanres.16572
3. Malignant neoplasms in Russia in 2023 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2024. 276 p. (In Russ.).
4. Yu M., Li X., Chen M. et al. Prognostic potential of nutritional risk screening and assessment tools in predicting survival of patients with pancreatic neoplasms: a systematic review. Nutr J 2024;23(1):17. DOI: 10.1186/s12937-024-00920-w
5. Poulia K.A., Sarantis P., Antoniadou D. et al. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients 2020;12(6):1543. DOI: 10.3390/nu12061543
6. Cintoni M., Grassi F., Palombaro M. et al. Nutritional interventions during chemotherapy for pancreatic cancer: a systematic review of prospective studies. Nutrients 2023;15(3):727. DOI: 10.3390/nu15030727
7. Muscaritoli M., Lucia S., Farcomeni A. et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget 2017;8(45):79884–96. DOI: 10.18632/oncotarget.20168
8. Carrato A., Cerezo L., Feliu J. et al. Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus. Clin Transl Oncol 2022;24(1):112–26. DOI: 10.1007/s12094-021-02674-x
9. Mękal D., Sobocki J., Badowska-Kozakiewicz A. et al. Evaluation of Nutritional status and the impact of nutritional treatment in patients with pancreatic cancer. Cancers (Basel) 2023;15(15):3816. DOI: 10.3390/cancers15153816
10. Laviano A., Di Lazzaro L., Koverech A. Nutrition support and clinical outcome in advanced cancer patients. Proc Nutr Soc 2018;77(4):388–93. DOI: 10.1017/S0029665118000459
11. Guidelines for clinical nutrition. Ed. by V.M. Luft. Saint Petersburg, Art-Express, 2016. (In Russ.).
12. Muscaritoli M., Arends J., Bachmann P. et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr 2021;40(5): 2898–913. DOI: 10.1016/j.clnu.2021.02.005
13. Sytov A.V., Zuzov S.A., Kukosh M.Yu. et al. Nutritional support. Zlokachestvennye opukholi = Malignant Tumors 2024;14(3s2): 163–73. (In Russ.). DOI: 10.18027/2224-5057-2023-13-3s2-2-132-142
14. De Haan J.J., Renken R.J., Moshage Y. et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer 2021;29(10):5691–9. DOI: 10.1007/s00520-021-06049-4
Review
For citations:
Tankieva F.U., Pak M.B., Berelavichus S.V., Rayevskaya M.B., Stashkiv V.I., Kirsanova E.A. Nutritional support for an oncological patient receiving intensive drug antitumor treatment: a clinical case. Head and Neck Tumors (HNT). 2025;15(2):109-115. (In Russ.) https://doi.org/10.17650/2222-1468-2025-15-2-109-115